Literature DB >> 26972473

Impact of chronobiology on neuropathic pain treatment.

Ian Gilron1,2,3.   

Abstract

Inflammatory pain exhibits circadian rhythmicity. Recently, a distinct diurnal pattern has been described for peripheral neuropathic conditions. This diurnal variation has several implications: advancing understanding of chronobiology may facilitate identification of new and improved treatments; developing pain-contingent strategies that maximize treatment at times of the day associated with highest pain intensity may provide optimal pain relief as well as minimize treatment-related adverse effects (e.g., daytime cognitive dysfunction); and consideration of the impact of chronobiology on pain measurement may lead to improvements in analgesic study design that will maximize assay sensitivity of clinical trials. Recent and ongoing chronobiology studies are thus expected to advance knowledge and treatment of neuropathic pain.

Entities:  

Keywords:  circadian rhythms; clinical trials; diurnal variation; neuropathic pain; nocturnal pain

Mesh:

Substances:

Year:  2016        PMID: 26972473     DOI: 10.2217/pmt-2015-0007

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  3 in total

1.  Modeling the daily rhythm of human pain processing in the dorsal horn.

Authors:  Jennifer Crodelle; Sofia H Piltz; Megan Hastings Hagenauer; Victoria Booth
Journal:  PLoS Comput Biol       Date:  2019-07-11       Impact factor: 4.475

2.  Diabetic Neuropathy Collection: Introduction to Diabetic Neuropathy.

Authors:  Uazman Alam
Journal:  Diabetes Ther       Date:  2020-02-17       Impact factor: 2.945

3.  Circadian Influences on Chemotherapy Efficacy in a Mouse Model of Brain Metastases of Breast Cancer.

Authors:  William H Walker; Samuel A Sprowls; Jacob R Bumgarner; Jennifer A Liu; O Hecmarie Meléndez-Fernández; James C Walton; Paul R Lockman; A Courtney DeVries; Randy J Nelson
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.